Gender and age-dependent differences in the mitochondrial apoptogenic pathway in Alzheimer's disease.

Age-related mitochondrial oxidative stress is highly gender dependent. The aim of this study was to determine the role of gender in the mitochondrial contribution to neuronal apoptosis in Alzheimer's disease (AD). We used mitochondria isolated from brains of Wistar rats to study the toxicity of ss-amyloid peptide (Ass), and found that it increases mitochondrial peroxide production, nitration and oxidation of proteins, and release of cytochrome c. The toxic effects occurred in young males and in old females but not in young females, indicating their resistance to Ass. This resistance was abolished with age. These toxic effects of Ass were prevented by heme. Our findings provide a molecular mechanism for the contribution of Abeta to the mitochondrial dysfunction and oxidative stress seen in AD, as well as for the mitochondria-dependent pathway of apoptosis in AD. Gender and age-related differences seen in the development of AD can also be partially explained.

[1]  Gregory J Brewer,et al.  Isolation and culture of adult rat hippocampal neurons , 1997, Journal of Neuroscience Methods.

[2]  J. Janowsky,et al.  Hormone replacement therapy and cognition: systematic review and meta-analysis. , 2001, JAMA.

[3]  R. Irwin,et al.  Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function , 2006, BMC Neuroscience.

[4]  F. Terro,et al.  Blockade of 12-lipoxygenase expression protects cortical neurons from apoptosis induced by β-amyloid peptide , 2004, Cell Death and Differentiation.

[5]  M. Beal,et al.  Are mitochondria critical in the pathogenesis of Alzheimer's disease? , 2005, Brain Research Reviews.

[6]  J. Sastre,et al.  17β‐oestradiol up‐regulates longevity‐related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFκB cascade , 2005 .

[7]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[8]  W. Frey,et al.  A role for heme in Alzheimer's disease: heme binds amyloid beta and has altered metabolism. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[9]  T. Bayer,et al.  A modified β‐amyloid hypothesis: intraneuronal accumulation of the β‐amyloid peptide – the first step of a fatal cascade , 2004, Journal of neurochemistry.

[10]  J. Sastre,et al.  Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. , 2003, Free radical biology & medicine.

[11]  G. Perry,et al.  Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients , 2004, Aging cell.

[12]  M. Smith,et al.  Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. , 1998, The American journal of pathology.

[13]  L. Lue,et al.  Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .

[14]  Xi Chen,et al.  Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A␤ to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .

[15]  M. D'Andrea,et al.  Intracellular accumulation of β-amyloid1–42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer’s disease , 2002, Neuroscience.

[16]  Kathleen A. Boyle,et al.  Amyloid-β peptide binds with heme to form a peroxidase: Relationship to the cytopathologies of Alzheimer’s disease , 2006 .

[17]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[18]  G. Barja Mitochondrial Free Radical Production and Aging in Mammals and Birds a , 1998, Annals of the New York Academy of Sciences.

[19]  R. Swerdlow,et al.  Functional mitochondria are required for amyloid β‐mediated neurotoxicity , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  L. Mucke,et al.  Intracellularly generated amyloid‐β peptide counteracts the antiapoptotic function of its precursor protein and primes proapoptotic pathways for activation by other insults in neuroblastoma cells , 2004, Journal of neurochemistry.

[21]  H. Atamna Heme binding to Amyloid-β peptide: Mechanistic role in Alzheimer's disease , 2006 .

[22]  Xiongwei Zhu,et al.  Apoptosis in Alzheimer disease: a mathematical improbability. , 2006, Current Alzheimer research.

[23]  Xiongwei Zhu,et al.  Compensatory responses induced by oxidative stress in Alzheimer disease. , 2006, Biological research.

[24]  R. Swerdlow,et al.  Induction of cytochrome c-mediated apoptosis by amyloid β 25-35 requires functional mitochondria , 2002, Brain Research.

[25]  G. Orphanides,et al.  Induction of iron homeostasis genes during estrogen-induced uterine growth and differentiation , 2006, Molecular and Cellular Endocrinology.

[26]  M. Tabaton,et al.  Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress , 1998, Journal of neurochemistry.

[27]  Xiongwei Zhu,et al.  Abortive apoptosis in Alzheimer's disease , 2001, Acta Neuropathologica.

[28]  M. Yao,et al.  Estrogen Regulates Bcl-w and Bim Expression: Role in Protection against β-Amyloid Peptide-Induced Neuronal Death , 2007, The Journal of Neuroscience.